UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~April~~May 2226, 2026

HEALTHCARE SERVICES GROUP, INC.

(Exact name of registrant as specified in its charter)

Commission File Number: 0-12015


Pennsylvania			23-2018365
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification number)

3220 Tillman Drive, Suite 300, Bensalem, Pennsylvania

(Address of principal executive office)

19020

(Zip Code)

Registrant's telephone number, including area code: (215-) 639-4274

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

( ☐ ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

( ☐ ) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

( ☐ ) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

( ☐ ) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value	HCSG	NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o☐

Item 25.0207 ~~Results~~Submission of ~~Operations~~Matters ~~and~~to ~~Financial~~a ~~Condition.~~Vote of Security Holders

On ~~April~~Tuesday, May 2226, 2026, ~~Healthcare~~the ~~Services~~Company ~~Group,~~held ~~Inc.~~its ~~(the~~annual ~~"Company")~~meeting ~~issued~~of ashareholders ~~press~~for ~~release~~the (purposes of voting on the ~~"Press~~matters ~~Release")~~disclosed ~~announcing~~in its ~~earnings~~definitive ~~for~~Proxy Statement on Schedule 14A filed with the ~~three~~Securities ~~months~~and ~~ended~~Exchange ~~March~~Commission 31on April 15, 2026. AAs ~~copy~~ of the ~~Press~~Record ~~Release~~Date isof ~~being~~March 30, ~~furnished~~2026, ~~hereto~~there aswere ~~Exhibit~~approximately ~~99.1~~68,954,000 shares of common stock outstanding and isentitled ~~hereby~~to ~~incorporated~~notice byof ~~reference~~and to ~~this~~vote ~~Current~~at ~~Report~~the annual meeting. The final voting for the matters submitted to a vote of shareholders are as follows.

~~The~~Management information furnished herein, including Exhibit 99.1 shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.Proposals:

Proposal No. 1 — Election of Directors

At the annual meeting, shareholders voted for the election of nine Directors for a one-year term or until their successors are elected and qualified to fill the expiring terms of such Directors. All of the Company’s nominees for Director received the requisite plurality (i.e. the highest number of votes of the Company’s common stock in accordance with the bylaws of the Company and Section 1758 of the Pennsylvania Business Corporation Law) of the votes cast by the holders of shares present at the meeting in person or by proxy and entitled to vote thereon, and, accordingly, were elected to the Board of Directors for the ensuing year or until their successors are duly elected and qualified. The voting results are set forth below:


Nominee	Votes For	Votes Withheld	Broker Non-Votes
Diane S. Casey	60,583,583	1,916,149	3,607,184
Daniela Castagnino	61,706,486	793,246	3,607,184
Laura Grant	61,706,736	792,996	3,607,184
Thomas M. Gallagher	62,144,612	355,120	3,607,184
Dino D. Ottaviano	60,733,763	1,765,969	3,607,184
Kurt Simmons, Jr.	61,646,252	853,480	3,607,184
Jude Visconto	60,947,847	1,551,885	3,607,184
Theodore Wahl	61,322,013	1,177,719	3,607,184
Thomas G. Whalen	61,997,269	502,463	3,607,184

Proposal No. 2 — Say on Pay Vote

The proposal relating to an advisory vote on a non-binding resolution to approve the compensation of the Company's named executive officers (the “Say on Pay Vote”) has received a majority of the votes cast as follows:


Votes For	Votes Against	Abstain	Broker Non-Votes
61,059,063	1,305,516	135,153	3,607,184

Proposal No. 3 — Independent Registered Public Accounting Firm

The proposal for the ratification of the selection of Grant Thornton LLP as the Company's independent registered public accountants for the current fiscal year ending December 31, 2026 has received a majority of the votes cast as follows:


Votes For	Votes Against	Abstain	Broker Non-Votes
64,821,277	1,247,022	38,617	—

Proposal No. 4 — Amendment to the 2020 Omnibus Plan

The proposal relating to shareholder approval to amend the 2020 Omnibus Plan to increase the number of shares of Common Stock that are available for issuance thereunder by 2,500,000 has received a majority of the votes cast as follows:


Votes For	Votes Against	Abstain	Broker Non-Votes
59,690,433	2,747,530	61,769	3,607,184


Item 9.01			Financial Statements and Exhibits.

( ad ) ~~Not~~Exhibits. ~~applicable~~The following exhibits are being furnished herewith:

( b ) Not applicable


Exhibit No.			Description
104			Cover page Interactive Data File (embedded within the Inline XBRL document)

( c ) Not applicable

( d ) Exhibits.

Exhibit Number						Description
99.1						Press Release and financial tables dated April 22, 2026, issued by Healthcare Services Group, Inc.
104						Cover page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		HEALTHCARE SERVICES GROUP, INC.
Date: April 22, 2026	By:	/s/ Vikas Singh
Date: May 26, 2026	By:	/s/ Jason J. Bundick
		Name: Vikas SinghTitle: Executive Vice President & Chief Financial Officer
		Name: Jason J. BundickTitle: General Counsel, Chief Compliance Officer & Secretary

Filing Compare · HEALTHCARE SERVICES GROUP INC